These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14518432)

  • 1. [EuroSIDA Study: downward trend of AIDS cases and AIDS mortality].
    Blasko M
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1814. PubMed ID: 14518432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decline in AIDS and death rates in the EuroSIDA study. An observational study].
    Kirk O; Mocroft A; Lundgren JD;
    Ugeskr Laeger; 2004 Jun; 166(26-31):2572-6. PubMed ID: 15285167
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group.
    Mocroft A; Ledergerber B; Viard JP; Staszewski S; Murphy M; Chiesi A; Horban A; Hansen AB; Phillips AN; Lundgren JD;
    J Infect Dis; 2004 Dec; 190(11):1947-56. PubMed ID: 15529259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
    Mocroft A; Ledergerber B; Zilmer K; Kirk O; Hirschel B; Viard JP; Reiss P; Francioli P; Lazzarin A; Machala L; Phillips AN; Lundgren JD;
    AIDS; 2007 Sep; 21(14):1867-75. PubMed ID: 17721094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression to AIDS and death in the era of HAART.
    Hill A
    AIDS; 2006 Apr; 20(7):1067-8. PubMed ID: 16603862
    [No Abstract]   [Full Text] [Related]  

  • 7. [Opportunistic diseases. Risk can be estimated].
    Marquardt T; Jablonowski H
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():33-7. PubMed ID: 15011582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy.
    d'Arminio Monforte A; Sabin CA; Phillips A; Sterne J; May M; Justice A; Dabis F; Grabar S; Ledergerber B; Gill J; Reiss P; Egger M;
    Arch Intern Med; 2005 Feb; 165(4):416-23. PubMed ID: 15738371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing incidence of central nervous system diseases in the EuroSIDA cohort.
    d'Arminio Monforte A; Cinque P; Mocroft A; Goebel FD; Antunes F; Katlama C; Justesen US; Vella S; Kirk O; Lundgren J;
    Ann Neurol; 2004 Mar; 55(3):320-8. PubMed ID: 14991809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of triple antiretroviral therapy on Tunisian AIDS profile: study of 139 cases].
    Zouiten F; Ammari L; Goubantini A; Tiouiri H; Slim A; Maamouri A; Kilani B; Kanoun F; Marrakchi C; Neifer N; Mihoub L; Jenhani F; Garbouj M; Ben Chaabane T
    Tunis Med; 2003 Dec; 81(12):956-62. PubMed ID: 14986532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?
    Borrell C; Rodríguez-Sanz M; Pasarín MI; Brugal MT; García-de-Olalla P; Marí-Dell'Olmo M; Caylà J
    Eur J Public Health; 2006 Dec; 16(6):601-8. PubMed ID: 16698886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of antiretroviral therapy on AIDS and survival.
    Lundgren JD; Mocroft A
    J HIV Ther; 2006 Jun; 11(2):36-8. PubMed ID: 16981594
    [No Abstract]   [Full Text] [Related]  

  • 14. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
    Olawumi HO; Olatunji PO; Salami AK; Odeigah L; Iseniyi JO
    Niger J Clin Pract; 2008 Dec; 11(4):312-5. PubMed ID: 19320401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.
    Brown TT; Cole SR; Li X; Kingsley LA; Palella FJ; Riddler SA; Visscher BR; Margolick JB; Dobs AS
    Arch Intern Med; 2005 May; 165(10):1179-84. PubMed ID: 15911733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XIII international AIDS Conference: new thoughts on treatment in all worlds.
    Laurence J
    AIDS Read; 2000 Aug; 10(8):452-3. PubMed ID: 10967797
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS-related Kaposi's sarcoma in a patient with a normal CD4 count.
    Power DG; Mulholland PJ; O'Byrne KJ
    Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):97. PubMed ID: 17954026
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.